Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders

Movement Disorders

Volumn 25, Issue 2, 2010, Pages 172-178

  Louis, Elan D ^a,b,c   Tang, Ming X ^a,c   Schupf, Nicole ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NONE   (United States)

^c NONE   (United States)

Author keywords

Alzheimer's disease; Elderly; Epidemiology; Incident dementia; Mild parkinsonian signs; Population

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DEMENTIA; EDUCATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HAZARD RATIO; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSONISM; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RACE; RISK FACTOR; STROKE; UNIFIED PARKINSON DISEASE RATING SCALE; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MUSCLE RIGIDITY; NEUROPSYCHOLOGICAL TESTS; NEW YORK CITY; PARKINSON DISEASE; POPULATION GROUPS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 77649096754     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22943     Document Type: Article

References (45)

1. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
2. Louis ED, Luchsinger JA, Tang MX, Mayeux R. Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology 2003;61:24-28.
3. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonian-like signs and risk of incident Alzheimer disease in older persons. Arch Neurol 2003;60:539-544.
4. Bennett DA, Shannon KM, Beckett LA, Wilson RS. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 1999;54:M191-M196.
5. Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol 2005;62:297-302.
6. Fleischman DA, Wilson RS, Schneider JA, Bienias JL, Bennett DA. Parkinsonian signs and functional disability in old age. Exp Aging Res 2007;33:59-76.
7. Mitchell SL, Rockwood K. The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach. J Am Geriatr Soc 2000;48:422-425.
8. Louis ED, Tang MX, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol 2004;61:1273-1276.
9. Stern Y, Andrews, H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49:453-460.
10. Cosentino S, Scarmeas N, Helzner E, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008;70(19 Pt 2):1842-1849.
11. Tang MX, Cross P, Andrews H, et al. Incidence of Alzheimer's disease in African-Americans, Caribbean Hispanics and Caucasians in northern Manhattan. Neurology 2001;56:49-56.
12. Fahn S, Elton R; Members of the UPDRS Development Committee. In: Fahn S MC, Goldtein M, Calne DB, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information; 1987. p 153-163.
13. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-1281.
14. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007;68:326-337.
15. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.
16. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 2005;64:1157-1161.
17. Louis ED, Marder K, Tabert MH, Devanand DP. Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly. Mov Disord 2008;23:524-530.
18. Louis ED, Schupf N, Marder K, Tang MX. Functional correlates of mild parkinsonian signs in the community-dwelling elderly: poor balance and inability to ambulate independently. Mov Disord 2006;21:411-416.
19. Louis ED, Tang MX, Mayeux R. Factor structure of parkinsonian signs in the community-dwelling elderly. Mov Disord 2004;19: 268-272.
20. Louis ED, Luchsinger JA. History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals. Arch Neurol 2006;63:717-722.
21. Scarmeas N, Levy G, Tang MX, et al. Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 2001;57: 2236-2242.
22. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 2005;64:1157-1161
23. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009;66:216-225.
24. Devanand DP, Tabert MH, Cuasay K, et al. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 2008 (Epub].
25. Spitzer RWJ. Structured clinical interview for DSM III-R - Hamilton version. New York: New York State Psychiatric Institute; 1986.
26. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
27. Schwab J, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillinghan FS, Donaldson MN, editors. Third symposium on Parkinson's disease. Edinburg, Scotland: E & S Livingstone; 1969. p 152-157.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
29. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
30. Benton AL, Hamsher K. Multilingual aphasia examination. Iowa City, IA: University of Iowa; 1976.
31. Goodglass H, Kaplan E. The assessment of aphasia and related disorders, second ed. Philadelphia, PA: Lea & Febiger; 1983.
32. Buschke H, Fuld P. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;4:1019-1025.
33. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10:77-84.
34. Grunebaum MF, Oquendo MA, Manly JJ. Depressive symptoms and antidepressant use in a random community sample of ethnically diverse, urban elder persons. J Affect Disord 2008;105(1-3):273-277.
35. Larson EB, Kukull WA, Katzman RL. Cognitive impairment: dementia and Alzheimer's disease. Annu Rev Public Health 1992;13:431-449.
36. Mayeux R, Schupf N. Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine. Am J Public Health 1995;85:1280-1284.
37. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445-453.
38. McDowell I. Alzheimer's disease: insights from epidemiology. Aging (Milano) 2001;13:143-162.
39. Siedlecki KL, Honig LS, Stern Y. Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease. Neuropsychology 2008;22:400-411.
40. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease. Arch Neurol 1999;56:334-337.
41. Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 1997;41:368-374.
42. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 2005;64:1397-1403.
43. Bermejo-Pareja F, Louis ED, Benito-Leon J. Risk of incident dementia in essential tremor: a population-based study. Mov Disord 2007;22:1573-1580.
44. Thawani S, Schupf N, Louis ED. Essential tremor is associated with dementia: prospective population-based study in New York. Neurology 2009;73:621-625.
45. Camicioli R, Wang Y, Powell C, Mitnitski A, Rockwood K. Gait and posture impairment, parkinsonism and cognitive decline in older people. J Neural Transm 2007;114:1355-1361.